1 Year Total Returns (Daily) Chart

View 1 Year Total Returns (Daily) for TOVX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View 1 Year Total Returns (Daily) Chart
Start Trial

Historical 1 Year Total Returns (Daily) Data

View and export this data back to 2004. Start Trial.
Date Value
September 11, 2026 -41.13%
September 10, 2026 -41.09%
September 09, 2026 -37.80%
September 08, 2026 -36.27%
September 04, 2026 -35.16%
September 03, 2026 -41.16%
September 02, 2026 -39.16%
September 01, 2026 -39.27%
August 31, 2026 -39.02%
August 28, 2026 -40.77%
August 27, 2026 -39.77%
August 26, 2026 -42.04%
August 25, 2026 -44.65%
August 24, 2026 -45.13%
August 21, 2026 -45.29%
August 20, 2026 -47.80%
August 19, 2026 -47.09%
August 18, 2026 -48.75%
August 17, 2026 -48.68%
August 14, 2026 -47.59%
August 13, 2026 -47.46%
August 12, 2026 -44.15%
August 11, 2026 -45.63%
August 10, 2026 -37.74%
August 07, 2026 -43.38%
Date Value
August 06, 2026 -42.40%
August 05, 2026 -44.69%
August 04, 2026 -46.12%
August 03, 2026 -48.58%
July 31, 2026 -52.94%
July 30, 2026 -50.73%
July 29, 2026 -50.34%
July 28, 2026 -55.72%
July 27, 2026 -57.40%
July 24, 2026 -54.87%
July 23, 2026 -57.28%
July 22, 2026 -53.82%
July 21, 2026 -52.32%
July 20, 2026 -52.59%
July 17, 2026 -49.48%
July 16, 2026 -50.99%
July 15, 2026 -48.25%
July 14, 2026 -51.69%
July 13, 2026 -53.39%
July 10, 2026 -48.54%
July 09, 2026 -50.13%
July 08, 2026 -48.75%
July 07, 2026 -45.27%
July 06, 2026 -42.82%
July 02, 2026 -44.22%

Total Return Definition

The Total return is the change in price over a specific period of time that includes dividends and distributions paid.

Read full definition.

1 Year Total Returns (Daily) Range, Past 5 Years

View 1 Year Total Returns (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

1 Year Total Returns (Daily) Benchmarks

View 1 Year Total Returns (Daily) Benchmarks
Start Trial
Ironwood Pharmaceuticals, Inc. 229.0%
Yarrow Bioscience, Inc. 206.4%
Nkarta, Inc. 40.58%
Unicycive Therapeutics, Inc. 29.34%
OnKure Therapeutics, Inc. 27.05%